SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-375238
Filing Date
2015-11-12
Accepted
2015-11-12 13:09:13
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d54371d10q.htm 10-Q 194734
2 EX-31.1 d54371dex311.htm EX-31.1 6247
3 EX-31.2 d54371dex312.htm EX-31.2 6216
4 EX-32.1 d54371dex321.htm EX-32.1 4387
  Complete submission text file 0001193125-15-375238.txt   1323194

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxgn-20150930.xml EX-101.INS 180270
6 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20150930.xsd EX-101.SCH 20052
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20150930_cal.xml EX-101.CAL 22722
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20150930_def.xml EX-101.DEF 35311
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20150930_lab.xml EX-101.LAB 176797
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20150930_pre.xml EX-101.PRE 106320
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 151223106
SIC: 2836 Biological Products, (No Diagnostic Substances)